Chinese herbal medicine Shufeng Jiedu capsule for mild to moderate COVID-19: a multicenter, randomized, double-blind, placebo-controlled phase II trial

Background: The COVID-19 pandemic has had a profound global impact, although the majority of recently infected cases have presented with mild to moderate symptoms. Previous clinical studies have demonstrated that Shufeng Jiedu (SFJD) capsule, a Chinese herbal patent medicine, effectively alleviates...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Chun-li Lu, Liu-qing Yang, Xin-yan Jin, Thomas Friedemann, Yu-fei Li, Xue-han Liu, Xiao-ying Chen, Xiang-yun Zou, Bing-rui Zhang, Fu-xiang Wang, Yuan-long Lin, Yi-min Tang, Meng-li Cao, Ya-lin Jiang, You-fang Gao, Kui Liu, Zhen-gang Tao, Nicola Robinson, Sven Schröder, Jian-ping Liu, Hong-zhou Lu
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2024-05-01
coleção:	Frontiers in Pharmacology
Assuntos:	Shufeng Jiedu capsules COVID-19 Chinese herbal medicine symptom relief randomized control trial
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1383831/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!